Cargando…

Safety evaluation of high-risk myocardial micro-biopsy in a swine model

The objective of the study was to investigate the safety profile of high-risk micro-endomyocardial biopsy (micro-EMB) compared to conventional EMB in a large animal model. Twenty pigs were subjected to a maximum of 30 consecutive biopsies, including sampling from the free ventricular wall, with eith...

Descripción completa

Detalles Bibliográficos
Autores principales: Chireh, Arvin, Sandell, Mikael, Grankvist, Rikard, Lövljung, Victoria, al-Saadi, Jonathan, Arnberg, Fabian, Lundberg, Johan, Settergren, Magnus, Holmin, Staffan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917023/
https://www.ncbi.nlm.nih.gov/pubmed/34812914
http://dx.doi.org/10.1007/s00380-021-01995-9
_version_ 1784668451902586880
author Chireh, Arvin
Sandell, Mikael
Grankvist, Rikard
Lövljung, Victoria
al-Saadi, Jonathan
Arnberg, Fabian
Lundberg, Johan
Settergren, Magnus
Holmin, Staffan
author_facet Chireh, Arvin
Sandell, Mikael
Grankvist, Rikard
Lövljung, Victoria
al-Saadi, Jonathan
Arnberg, Fabian
Lundberg, Johan
Settergren, Magnus
Holmin, Staffan
author_sort Chireh, Arvin
collection PubMed
description The objective of the study was to investigate the safety profile of high-risk micro-endomyocardial biopsy (micro-EMB) compared to conventional EMB in a large animal model. Twenty pigs were subjected to a maximum of 30 consecutive biopsies, including sampling from the free ventricular wall, with either micro-EMB (n = 10) or conventional EMB (n = 10). There were no major complications in the micro-EMB group (0/10), compared to six major complications in the EMB group (6/10; p = 0.003). Survival analysis further highlighted these differences (p = 0.004). There were significantly higher volumes of pericardial effusion in the EMB group (p = 0.01). The study shows a safety advantage of micro-EMB compared to standard EMB in the experimental high-risk circumstances investigated in this animal study. These results indicate enhanced possibilities to collect samples from sensitive areas by using the micro-EMB technique instead of standard EMB. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-021-01995-9.
format Online
Article
Text
id pubmed-8917023
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-89170232022-03-17 Safety evaluation of high-risk myocardial micro-biopsy in a swine model Chireh, Arvin Sandell, Mikael Grankvist, Rikard Lövljung, Victoria al-Saadi, Jonathan Arnberg, Fabian Lundberg, Johan Settergren, Magnus Holmin, Staffan Heart Vessels Original Article The objective of the study was to investigate the safety profile of high-risk micro-endomyocardial biopsy (micro-EMB) compared to conventional EMB in a large animal model. Twenty pigs were subjected to a maximum of 30 consecutive biopsies, including sampling from the free ventricular wall, with either micro-EMB (n = 10) or conventional EMB (n = 10). There were no major complications in the micro-EMB group (0/10), compared to six major complications in the EMB group (6/10; p = 0.003). Survival analysis further highlighted these differences (p = 0.004). There were significantly higher volumes of pericardial effusion in the EMB group (p = 0.01). The study shows a safety advantage of micro-EMB compared to standard EMB in the experimental high-risk circumstances investigated in this animal study. These results indicate enhanced possibilities to collect samples from sensitive areas by using the micro-EMB technique instead of standard EMB. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-021-01995-9. Springer Japan 2021-11-23 2022 /pmc/articles/PMC8917023/ /pubmed/34812914 http://dx.doi.org/10.1007/s00380-021-01995-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Chireh, Arvin
Sandell, Mikael
Grankvist, Rikard
Lövljung, Victoria
al-Saadi, Jonathan
Arnberg, Fabian
Lundberg, Johan
Settergren, Magnus
Holmin, Staffan
Safety evaluation of high-risk myocardial micro-biopsy in a swine model
title Safety evaluation of high-risk myocardial micro-biopsy in a swine model
title_full Safety evaluation of high-risk myocardial micro-biopsy in a swine model
title_fullStr Safety evaluation of high-risk myocardial micro-biopsy in a swine model
title_full_unstemmed Safety evaluation of high-risk myocardial micro-biopsy in a swine model
title_short Safety evaluation of high-risk myocardial micro-biopsy in a swine model
title_sort safety evaluation of high-risk myocardial micro-biopsy in a swine model
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917023/
https://www.ncbi.nlm.nih.gov/pubmed/34812914
http://dx.doi.org/10.1007/s00380-021-01995-9
work_keys_str_mv AT chireharvin safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel
AT sandellmikael safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel
AT grankvistrikard safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel
AT lovljungvictoria safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel
AT alsaadijonathan safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel
AT arnbergfabian safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel
AT lundbergjohan safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel
AT settergrenmagnus safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel
AT holminstaffan safetyevaluationofhighriskmyocardialmicrobiopsyinaswinemodel